SCHEMBL8569773

SCHEMBL8569773

C[SiH](OCC(O[SiH](C)C(C)(C)C)c1c(N)nc(SCc2ccc3ccccc3c2)nc1O)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 1/20 0.34
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2E1 P05181 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C8 P10632 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2B6 P20813 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HTR2A P28223 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ HTR2B P41595 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CXCR2 P25025 1/20 0.30
▸ TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8599345 0.77 HTR2A (0.43) DAOCYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL6639377 0.68 DAO (0.47) DAOCYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL8569771 0.68 DAO (0.34) DAOCYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL6639145 0.67 CYP1A2 (0.48) DAOCYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL6641821 0.67 POLB (0.54) NPC1RAB9ASMN1; SMN2CXCR2
SCHEMBL6636642 0.66 DAO (0.47) DAOCYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL8125458 0.65 HSP90AA1 (0.44) DAOCYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL6643920 0.64 RAB9A (0.56) DAOCYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL6635668 0.63 RAB9A (0.43) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL8571334 0.63 CYP1A2 (0.44) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0824524-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1998-02-25 — — EP disclosed
Send feedback